Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Telaprevir for genotype 1 chronic hepatitis C: a systematic review and meta-analysis.

Gu L, Chen Q, Xie J, Yan Y, Wu G, Tan J, Liang B, Chen W, Wu P, Su L, Tang N.

Pharmazie. 2012 Dec;67(12):963-72. Review.

PMID:
23346756
2.

Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C.

Hauser G, Awad T, Brok J, Thorlund K, Štimac D, Mabrouk M, Gluud C, Gluud LL.

Cochrane Database Syst Rev. 2014 Feb 28;(2):CD005441. Review.

PMID:
24585509
3.

Telaprevir: a hepatitis C NS3/4A protease inhibitor.

Matthews SJ, Lancaster JW.

Clin Ther. 2012 Sep;34(9):1857-82. doi: 10.1016/j.clinthera.2012.07.011. Epub 2012 Aug 28. Review.

PMID:
22951253
4.

WITHDRAWN: Ribavirin with or without alpha interferon for chronic hepatitis C.

Gluud LL, Krogsgaard K, Gluud C.

Cochrane Database Syst Rev. 2007 Jul 18;(2):CD002234. Review.

PMID:
17636700
5.

Ribavirin with or without alpha interferon for chronic hepatitis C.

Kjaergard LL, Krogsgaard K, Gluud C.

Cochrane Database Syst Rev. 2002;(2):CD002234. Review. Update in: Cochrane Database Syst Rev. 2002;(2):CD002234.

PMID:
12076442
6.
7.
8.

Telaprevir.

[No authors listed]

Prescrire Int. 2012 Apr;21(126):93-6.

PMID:
22515133
9.

Aminoadamantanes for chronic hepatitis C.

Lamers MH, Broekman M, Drenth JP, Gluud C.

Cochrane Database Syst Rev. 2014 May 3;(5):CD010125. doi: 10.1002/14651858.CD010125.pub2. Review.

PMID:
24793264
10.

[Efficacy and safety of a protease inhibitor with pegylated interferon and ribavirin in patients with untreated chronic hepatitis C: a meta analysis].

Yuan XL, Li MY, Zhang DZ.

Zhonghua Gan Zang Bing Za Zhi. 2012 May;20(5):357-62. doi: 10.3760/cma.j.issn.1007-3418.2012.05.011. Chinese.

PMID:
22971281
11.

Ribavirin plus interferon versus interferon for chronic hepatitis C.

Brok J, Gluud LL, Gluud C.

Cochrane Database Syst Rev. 2010 Jan 20;(1):CD005445. doi: 10.1002/14651858.CD005445.pub2. Review.

PMID:
20091577
12.

Ribavirin monotherapy for chronic hepatitis C.

Brok J, Gluud LL, Gluud C.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD005527. doi: 10.1002/14651858.CD005527.pub2. Review.

PMID:
19821346
13.

Safety of telaprevir for chronic hepatitis C virus infection: a meta-analysis of randomized controlled trials.

Qin H, Li H, Zhou X, Feng F, Shen Y, Tan H, Ye F, Xie Y.

Clin Drug Investig. 2012 Oct 1;32(10):665-72. doi: 10.2165/11633240-000000000-00000. Review.

PMID:
22889114
14.

Efficacy of telaprevir and boceprevir in treatment-naïve and treatment-experienced genotype 1 chronic hepatitis C patients: an indirect comparison using Bayesian network meta-analysis.

Cure S, Diels J, Gavart S, Bianic F, Jones E.

Curr Med Res Opin. 2012 Nov;28(11):1841-56. doi: 10.1185/03007995.2012.734798. Epub 2012 Oct 31.

PMID:
23016967
15.

Ribavirin with or without alpha interferon versus no intervention, placebo or alpha interferon for chronic hepatitis C.

Kjaergard LL, Krogsgaard K, Gluud C.

Cochrane Database Syst Rev. 2002;(1):CD002234. Review. Update in: Cochrane Database Syst Rev. 2002;(2):CD002234.

PMID:
11869633
16.

Telaprevir: an oral protease inhibitor for hepatitis C virus infection.

Kim JJ, Culley CM, Mohammad RA.

Am J Health Syst Pharm. 2012 Jan 1;69(1):19-33. doi: 10.2146/ajhp110123. Review.

PMID:
22180548
17.

Ribavirin plus interferon versus interferon for chronic hepatitis C.

Brok J, Gluud LL, Gluud C.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD005445. Review. Update in: Cochrane Database Syst Rev. 2010;(1):CD005445.

PMID:
16034976
18.

Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options.

Jacobson IM, Gordon SC, Kowdley KV, Yoshida EM, Rodriguez-Torres M, Sulkowski MS, Shiffman ML, Lawitz E, Everson G, Bennett M, Schiff E, Al-Assi MT, Subramanian GM, An D, Lin M, McNally J, Brainard D, Symonds WT, McHutchison JG, Patel K, Feld J, Pianko S, Nelson DR; POSITRON Study; FUSION Study.

N Engl J Med. 2013 May 16;368(20):1867-77. doi: 10.1056/NEJMoa1214854. Epub 2013 Apr 23.

19.

Interferon for interferon naive patients with chronic hepatitis C.

Myers RP, Regimbeau C, Thevenot T, Leroy V, Mathurin P, Opolon P, Zarski JP, Poynard T.

Cochrane Database Syst Rev. 2002;(2):CD000370. Review.

PMID:
12076394

Supplemental Content

Support Center